Stay updated with the latest news and articles about OptiNose.
Coeptis Therapeutics Holdings, Inc. declined by −96.03%, with its stock priced at 2.46 USD and a market capitalization of 6.37 M USD.
Coeptis Therapeutics Holdings, Inc. saw a drastic drop of −96.03%, with its stock priced at 2.46 USD and a market cap of 6.37 M USD.
Coeptis Therapeutics Holdings, Inc. plunged by −95.79%, trading at 2.61 USD, with a market cap of 6.37 M USD.
Coeptis Therapeutics Holdings, Inc. experienced a sharp decline of −95.98%, trading at 2.49 USD with a market cap of 6.37 M USD.